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Abstract: The purpose of the study was to investigate the antioxidant characteristics of 
Anisomeles  indica  methanol  extract  and  the  inhibitory  effect  of  ovatodiolide  on 
melanogenesis. In the study, the antioxidant capacities of A. indica methanol extract such 
as DPPH assay, ABTS radical scavenging assay, reducing capacity and metal ion chelating 
capacity as well as total phenolic content of the extract were investigated. In addition, the 
inhibitory effects of ovatodiolide on mushroom tyrosinase, B16F10 intracellular tyrosinase 
and melanin content were determined spectrophotometrically. Our results revealed that the 
antioxidant capacities of A. indica methanol extract increased in a dose-dependent pattern. 
The purified ovatodiolide inhibited mushroom tyrosinase activity (IC50 = 0.253 mM), the 
compound also effectively suppressed intracellular tyrosinase activity (IC50 = 0.469 mM) 
and decreased the amount of melanin (IC50 = 0.435 mM) in a dose-dependent manner in 
B16F10 cells. Our results concluded that A. indica methanol extract displays antioxidant 
capacities and ovatodiolide purified from the extract inhibited melanogenesis in B16F10 
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cells. Hence, A. indica methanol extract and ovatodiolide could be applied as a type of 
dermatological whitening agent in skin care products. 
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1. Introduction 
Free radicals are atoms or molecules which carry an unpaired electron. For example, the superoxide 
anion, hydroxyl radical and peroxyl radical are three common short-lived and chemically reactive free 
radicals. Additionally, reactive oxygen species (ROS) such as singlet oxygen, molecular oxygen and 
hydrogen peroxide (H2O2) are not free radicals, but are able to initiate oxidative reactions and generate  
free-radical species. Certainly, the cellular enzymes and controlled metabolic pathways ordinarily keep 
cellular oxidative damage to a minimum level [1–3]. Furthermore, it is reported that UV light radiation 
causes  protein  oxidation,  DNA  damage  and  induces  the  synthesis  of  ROS  in  skin,  which  in  turn 
induces aging-related disorders or melanogenesis. Therefore, the use of natural botanical antioxidants 
to protect human skin from the harmful effects of UV radiation is highly topical, having attracted 
increasing interest in recent years [4]. 
Melanin  is  a  pigment  produced  by  melanocytes  and  is  responsible  for  skin  color  as  well  as 
protecting the skin from UV-induced injury [5]. However, overproduction or accumulation of melanin 
results  in  several  dermatological  disorders,  including  melasma,  age  spots,  freckles,  and  other 
hyperpigmentation  syndromes  [6].  In  the  processes  of  melanin  biosynthesis,  tyrosinase  is  the  key 
enzyme in the rate-limiting step in which L-tyrosine is hydroxylated to L-DOPA (O-diphenol product), 
and L-DOPA is further oxidized into the corresponding O-quinone [7]. Hence, tyrosinase is a major 
target in screening inhibitors of melanin synthesis.  Besides, it is reported that  L-DOPA could also 
autoregulate itself and regulate the melanocyte functions through intermediates of melanogenesis and 
through the activity of structural or regulatory melanocytes [8]. Furthermore, it has been reported that 
microphthalmia-associated transcription factor (MITF) and other enzymes such as tyrosinase related 
protein-1  (TRP-1)  and  tyrosinase  related  protein-2  (TRP-2)  also  contribute  to  the  production  of 
melanin [9–11]. Recently, many melanogenesis inhibitors have been growingly applied in skin care 
cosmetics for the prevention of hyperpigmentation [12]. Interestingly, melanogenesis is reported to 
produce hydrogen peroxide and other ROS which subjects the melanocytes under high-grade oxidative 
stress. It is reported that ROS play a significant role in the regulation of melanogenesis, while ROS 
scavengers and inhibitors  of ROS  generation may  down-regulate UV-induced melanogenesis  [13]. 
Therefore, several antioxidants, such as ascorbic derivatives and reduced glutathione (GSH), have been 
applied as inhibitory agents of melanogenesis [14,15]. 
Anisomeles indica Kuntze (Labiatae) is a specific woody shrub in Taiwan and has been commonly 
used in traditional Chinese medicines for various disorders such as gastrointestinal disorders, liver 
disease and inflammatory skin diseases [16]. It is also reported that A. indica extracts and isolated 
constituents inhibit inflammatory mediators and tumor cell proliferation  [17–19]. Furthermore, the 
aqueous  extract  of  A.  indica  has  been  shown  to  show  anti-histaminerigic,  anti-hyperalgesic  and 
analgesic  activities  [20,21].  Recently,  the  ethanol  extract  of  A.  indica  exhibited  anti-bacterial  Int. J. Mol. Sci. 2012, 13  6222 
 
 
activity [22]. However, there is no scientific report about the dermatological application of the extract or 
pure compound of this plant. The aim of this study was to investigate the antioxidative characteristics of 
A. indica  methanol  extract  and evaluate the inhibitory effect  of ovatodiolide on melanogenesis  in 
B16F10 melanoma cells. 
2. Results and Discussion 
2.1. Purification of Ovatodiolide from A. indica Methanol Extract 
The HPLC chromatogram of A. indica methanol extract and ovatodiolide standard are shown in 
Figure 1. The retention time for purified ovatodiolide and standard were 23.579 and 23.534 min, 
respectively, which indicated the chemical purified from A. indica methanol extract was ovatodiolide. 
The chemical structure of ovatodiolide is shown in Figure 1c. 
Figure 1. (a), (b) HPLC chromatogram and (c) chemical structure of ovatodiolide. 
 
(a) 
   
(b)  (c) Int. J. Mol. Sci. 2012, 13  6223 
 
 
2.2. Determination of DPPH Scavenging Activity 
The antioxidant activity of A. indica methanol extract was first determined by measuring the DPPH 
scavenging ability of the extract. The extract showed DPPH radical scavenging activity as shown in 
Figure 2. DPPH scavenging activity of 0.05, 0.1, 0.25, 0.5, 1.0 and 1.5 mg/mL of the extract was  
12.94 ±  2.31%, 21.42 ±  1.36%, 43.34 ±  2.94%, 64.86 ±  0.35%, 72.31 ±  0.34% and 71.79 ±  1.49%  
(p  <  0.001)  of  control,  respectively.  Meanwhile,  the  DPPH  scavenging  activity  of  0.01,  0.02  and  
0.03 mg/mL of BHA was 52.04 ±  0.19%, 80.34 ±  2.61% and 88.54 ±  0.36% (p < 0.001) of control, 
respectively. Our results indicate that 0.05–1.0 mg/mL of A. indica methanol extract display DPPH 
free radical scavenging activity in a dose-dependent pattern. DPPH assay is a known useful method to 
give reliable information with regard to screening the antioxidant capacity of specific compounds or 
plant extracts. The results shown in Figure 2 imply that A. indica methanol extract displays DPPH free 
radical scavenging activity in a dose-dependent manner. The steric accessibility of the DPPH radical is 
a major determinant of the assay reaction, since some small molecules that have better access to the 
radical site could show higher antioxidant capacity. Besides, many large antioxidant chemicals that react 
quickly  with  peroxyl  radicals  may  react  slowly  in  a  DPPH  assay  [23].  Additionally,  the 
spectrophotometric analysis can be affected by the chemical structure of test compounds that absorb at 
the wavelength of determination or by the turbidity of the sample. 
Figure 2. DPPH radical scavenging effects of Anisomeles indica methanol extract. Various 
concentrations of the extract (final concentration 0.05, 0.1, 0.25, 0.5, 1.0 and 1.5 mg/mL) 
or BHA (0.01, 0.02 and 0.03 mg/mL) were interacted with DPPH, respectively. Results are 
represented  as  percentages  of  control,  and  the  data  are  mean  ±   SD  for  three  separate 
experiments. Values are significantly different by comparison with control. *** p < 0.001. 
 
2.3. Determination of ABTS
+ Radical Scavenging Capacity 
The ABTS
+ assay was employed to confirm the antioxidant activity of A. indica methanol extract. 
Different  concentrations  of  the  methanol  extract  (final  concentration  0.05,  0.1,  0.25,  0.5,  1.0  and  
1.5 mg/mL) or Trolox
® (0.025, 0.05, 0.075 and 0.1 mg/mL) were incubated with ABTS
+ solution, 
respectively. The ABTS
+ scavenging capacity of the methanol extract was 5.14 ±  1.36%, 13.42 ±  1.27%, 
42.84 ±  1.63%, 80.13 ±  0.91%, 96.83 ±  0.14% and 95.86 ±  0.09% of control for the extract at the Int. J. Mol. Sci. 2012, 13  6224 
 
 
concentration of 0.05, 0.1, 0.25, 0.5, 1.0 and 1.5 mg/mL, respectively (p < 0.001). Meanwhile, the 
ABTS
+  scavenging capacity of Trolox
®  (0.025, 0.05, 0.075 and 0.1 mg/mL) was  23.04  ±  1.22%,  
61.00 ±  2.96%, 98.78 ±  0.40% and 99.05 ±  0.03%, respectively (p < 0.001). The results indicated that 
the methanol extract of A. indica scavenges ABTS
+ free radical significantly in  a dose-dependent 
manner (0.05–1.0 mg/mL). Additionally, the maximum ABTS
+ radical scavenging capacity of methanol 
extract was slight weaker than that of Trolox
® (Figure 3). The ABTS
+ spectrophotometric analysis is a 
technically easy and simple method to screen potential antioxidant. The results shown in Figure 3 
indicate  that  the  methanol  extract  of  A.  indica  scavenges  ABTS
+  free  radical  significantly  in  a  
dose-dependent pattern (0.05–1.0 mg/mL). Thermodynamically, any sample that has a redox potential 
lower than that of ABTS
+ may react with the radical. Furthermore, the ABTS
+ radical is soluble in 
water and organic solvents, accounting for the determination of antioxidant capacity of hydrophilic and 
lipophilic samples. Furthermore, the results provided by the assay are dependent on time of analysis. 
Figure  3. ABTS
+ radical scavenging effects of A. indica methanol extract. The extract 
(final concentration 0.05, 0.1, 0.25, 0.5, 1.0 and 1.5 mg/mL) or Trolox
® (0.025, 0.05, 0.075 
and 0.1 mg/mL) were interacted with ABTS. Results are represented as percentages of 
control, and the data are mean ±  SD for three separate experiments. Values are significantly 
different by comparison with control. *** p < 0.001. 
 
2.4. Measurement of Reducing Capacity 
To determine the reducing capacity of A. indica methanol extract, various concentrations of the 
extract (0.05, 0.1, 0.2, 0.25, 0.3, 0.4 and 0.5 mg/mL) or BHA (0.01, 0.02, 0.03 mg/mL) were tested. 
The results shown in Figure 3 reveal that A. indica methanol extract exhibit reducing capacity in a 
dose-dependent  pattern.  Higher  concentrations  of  A.  indica  methanol  extract  present  apparent  
reducing capacity. The reducing capacities of 0.3, 0.4 and 0.5 (mg/mL) of the methanol extract were 
65.53 ±  0.63%, 80.07 ±  1.05% and 91.7 ±  1.91%, respectively. Meanwhile, the reducing capacities of 
0.01, 0.02 and 0.03 (mg/mL) of BHA were 37.48 ±  0.72, 70.98 ±  0.68, 37.48 ±  0.72 and 100 ±  2.35%, 
respectively (Figure 4). In this assay, the yellow color of the test solution changes to various shades of 
green and blue, depending on the reducing capacity of the test sample. Int. J. Mol. Sci. 2012, 13  6225 
 
 
Figure 4. Reducing capacity of A. indica methanol extract. Different concentrations of the 
extract (0.05, 0.1, 0.2, 0.25, 0.3, 0.4 and 0.5 mg/mL) or BHA (0.01, 0.02, 0.03 mg/mL) 
were used in the assay. Results are represented as percentages of control, and the data are 
mean ±  SD for three separate experiments. Values are significantly different by comparison 
with control. *** p < 0.001. 
 
2.5. Measurement of Metal Ion-Chelating Capacity 
Antioxidants may form insoluble metal complexes with ferrous ions and then inhibit interaction 
between metal and lipid. The metal-ion chelating ability of A. indica methanol extracts (0.05, 0.1, 0.25, 
0.5, 1.0, 1.5 and 2.0 mg/mL)  were 3.17  ±  1.37%, 4.54 ±  1.15%, 9.13  ±  3.64%, 25.18 ±  0.99%,  
48.48  ±   1.28%,  70.6  ±   1.98%  and  87.41  ±   1.89%  of  control,  respectively  (p  <  0.001).  On  the  
other hand, the metal-ion chelating capacity of 0.04, 0.05, 0.06, 0.07 and 0.08 mg/mL of EDTA were 
57.88  ±  1.55%, 67.72 ±  2.35%, 83.04 ±  0.81%, 94.06 ±  0.43% and 99.85 ±  0.11%, respectively  
(p < 0.001) (Figure 5). The results shown in Figure 5 indicate the dose-dependent metal-ion chelating 
capacity of A. indica methanol extract, and the extract may contain some special components that can 
chelate metal ions. The presence of antioxidants in the extract may cause the reduction of the Fe
3+ 
ferricyanide complex to the ferrous form. Hence, measuring the formation of blue color at 700 nm can 
monitor the Fe
2+ concentration [24]. The results shown in Figure 5 reveal that A. indica methanol 
extract chelate metal-ions in a dose-dependent pattern. Hence, the extract may contain some special 
components that can chelate metal ions. Int. J. Mol. Sci. 2012, 13  6226 
 
 
Figure  5.  Metal-ion  chelating  activity  of  A.  indica  methanol  extract.  Different 
concentrations  of  the  extract  (0.05,  0.1,  0.25,  0.5,  1.0,  1.5  and  2.0  mg/mL)  or  EDTA  
(0.04–0.08  mg/mL)  were  used  in  the  study.  Results  are  represented  as  percentages  of 
control, and the data are mean ±  SD for three separate experiments. Values are significantly 
different by comparison with control. *** p < 0.001. 
 
2.6. Measurement of Total Phenol Content 
To determine the amount of total phenolic contents of A. indica methanol extract (0.05, 0.1, 0.25, 
0.5, 1.0, 1.5 and 2.0 mg/mL), gallic acid (0.05, 0.1, 0.25 and 0.5 mg/mL) was used as positive standard. 
The results in Figure 6 show that the total phenolic contents in A. indica methanol extract were less 
than those of gallic acid. The phenolic content of 2.0 mg/mL of the methanol extract (53.90 ±  2.02%) 
was still less than that of 0.05 mg/mL of gallic acid (66.53 ±  3.02%). 
Figure 6. Determination of total phenolic content. Different concentrations of A. indica 
methanol extract (0.05, 0.1, 0.25, 0.5, 1.0, 1.5 and 2.0 mg/mL) and gallic acid (0.05, 0.1, 
0.25, 0.5 mg/mL) were used in the assay. Results are represented as percentages of control, 
and  the  data  are  mean  ±   SD  for  three  separate  experiments.  Values  are  significantly 
different by comparison with control. *** p < 0.001. 
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2.7. Inhibitory Effect of A. indica Methanol Extract and Ovatodiolide on Mushroom Tyrosinase Activity 
In  order  to  assay  the  possible  inhibitory  effect  of  A.  indica  methanol  extract  on  mushroom 
tyrosinase activity, dose-dependent inhibition experiments were carried out in triplicate. The results 
shown in Figure 7a indicate that mushroom tyrosinase activity was slightly inhibited by the various 
concentrations  of  A.  indica  methanol  extract  (final  concentration  0.25,  0.5  and  1.0  mg/mL)  in  a  
dose-dependent manner. The remained tyrosinase activity was 80.05 ±  1.38%, 76.36 ±  2.37% and 
74.86  ±   2.49%  of  control  for  0.25,  0.5  and  1.0  (mg/mL)  of  the  methanol  extract,  respectively  
(p < 0.001). Meanwhile, mushroom tyrosinase activity was inhibited by kojic acid (0.028 mg/mL) and 
residual enzyme activity was 64.37 ±  3.50% of control (p < 0.001). Hence, A. indica methanol extract 
seems  to  act  as  a  tyrosinase  inhibitor.  Interestingly,  the  results  shown  in  Figure  7b  indicate 
ovatodiolide displays a more potent inhibitory effect on mushroom tyrosinase activity than kojic acid  
(0.028 mg/mL). The observed mushroom tyrosinase activity was 66.60 ±  2.13%, 46.97 ±  2.21% and 
33.69 ±  1.08% of control for 0.02, 0.08 and 0.16 (mg/mL) of ovatodiolide, respectively (p < 0.001). 
The IC50 of ovatodiolide on mushroom tyrosinase activity is equal to 0.253 mM. The results shown in 
Figure  7a  indicate  that  mushroom  tyrosinase  activity  was  slightly  inhibited  by  the  various 
concentrations  of  A.  indica  methanol  extract  (final  concentration  0.25,  0.5  and  1.0  mg/mL)  in  a  
dose-dependent  manner. Actually, we also  determined the effect  of A. indica methanol  extract  on 
intracellular tyrosinase activity and melanin content in B16F10 cells. However, the extract displayed 
minor inhibitory effects on melanogenesis in B16F10 melanoma. In addition, the water extract of  
A.  indica  neither  inhibits  mushroom  tyrosinase  nor  suppresses  intracellular  tyrosinase  activity  in 
B16F10 cells (data not shown). 
Figure 7. Inhibitory effect of A. indica methanol extract and ovatodiolide on mushroom 
tyrosinase  activity.  Different  concentrations  of  (a)  the  methanol  extract  (0.25,  0.5,  
1.0 mg/mL); (b) ovatodiolide (0.02, 0.08 and 0.16 mg/mL) or kojic acid (0.028 mg/mL) 
were incubated with the same units of mushroom tyrosinase. Results are represented as 
percentages of control, and data are presented as mean ±  SD for three separate experiments. 
Values are significantly different by comparison with control. *** p < 0.001. 
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2.8. Inhibitory Effect of Ovatodiolide on Melanin Production 
To determine the antimelanogenic activity of ovatodiolide, the inhibitory effect of ovatodiolide on 
melanin content in B16F10 melanoma cells was assayed. B16F10 cells were first stimulated with  
α-MSH  (100  nM)  for  24  h,  and  then  cultured  in  the  presence  of  ovatodiolide  at  0.02,  0.08  and  
0.16 (mg/mL) or arbutin (0.545 mg/mL), respectively. Treatment with ovatodiolide showed a significant 
inhibitory effect on melanin synthesis in a dose-dependent pattern. The melanin content was represented 
as percentage of control. After treatment, the melanin content was 82.39 ±  1.18%, 60.66 ±  1.47% and 
47.83 ±  2.03% for 0.02, 0.08 and 0.16 (mg/mL) of ovatodiolide, respectively (p < 0.001) (Figure 8). 
The IC50 of ovatodiolide on B16F10 melanin content is 0.435 mM. Meanwhile, B16F10 cells were 
treated  with  arbutin  (0.545  mg/mL)  as  positive  standard,  and  the  remaining  intracellular  melanin 
content was 63.03 ±  2.91% of control for arbutin (p < 0.001). 
Figure 8. Effect of ovatodiolide on melanin synthesis in B16F10 cells. Melanin content 
assessment was performed as described in the ―Experimental Section‖. Briefly, cells were 
cultured with α-MSH (100 nM) for 24 h, and then the melanin content was measured after 
treatment  with  various  concentrations  of  ovatodiolide  (0.02,  0.08  and  0.16  mg/mL)  or 
arbutin (0.545 mg/mL) for another 24 h. Results are represented as percentages of control, 
and  data  are  presented  as  mean  ±   SD  for  three  separate  experiments.  Values  are 
significantly different by comparison with control. *** p < 0.001. 
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2.9. Inhibitory Effect of Ovatodiolide on B16F10 Tyrosinase Activity 
To examine the action mechanism of the inhibitory effect of ovatodiolide on melanogenesis more 
precisely, we assessed intracellular tyrosinase activity in B16F10 melanoma cells. The cells were first 
stimulated with α-MSH (100 nM) for 24 h, and then cultured with various concentrations of ovatodiolide 
(0.02, 0.08 and 0.16 mg/mL) or arbutin (0.545 mg/mL) for another 24 h. Ovatodiolide significantly 
inhibited α-MSH-induced tyrosinase activity in a dose-dependent pattern. After these treatments, the 
remaining intracellular tyrosinase activity was 78.27 ±  0.80%, 67.97 ±  2.78% and 48.03 ±  2.08% for 
0.02, 0.08 and 0.16 mg/mL of ovatodiolide, respectively (p < 0.001). The IC50 of ovatodiolide on 
B16F10 intracellular tyrosinase is  0.469 mM.  Meanwhile, the intracellular tyrosinase activity  was 
76.19 ±  4.47% after the cells were treated with arbutin (2.0 mM = 0.545 mg/mL) (p < 0.001) (Figure 9). 
Recently,  ovatodiolide  has  been  reported  to  show  several  pharmacological  activities,  including  
HIV-inhibitory effects [25], antiplatelet aggregation activities [17], anti-inflammatory activities [19], 
anti-metastatic  effects  on  human  breast  cancer  cells  [26]  and  induces  apoptosis  in  human  oral 
squamous cell carcinoma [27]. However, there are no reports about the dermatological application of 
ovatodiolide.  This  is  the  first  report  that  ovatodiolide  inhibits  intracellular  tyrosinase  activity  and 
decreases melanin content in a dose-dependent manner in the B16F10 melanoma cell model. In our 
unshown data, it was found that 0.008 mg/mL of ovatodiolide reduces 50% of intracellular  ROS 
content in B16F10 cells. Hence, it could be proposed that ovatodiolide inhibits melanogenesis in B16F10 
cells mediated by the depletion of intracellular ROS content. Certainly, the possible action mechanism 
of the inhibitory effect of ovatodiolide on melanogenesis will be elucidated in the near future. 
Figure 9. Effect of ovatodiolide on tyrosinase activity in B16F10 cells. Enzyme assay was 
performed as described in the ―Experimental Section‖. Briefly, B16F10 melanoma cells 
were stimulated with α-MSH (100 nM) for 24 h, and the cellular tyrosinase activity was 
assayed  after  treatment  with  ovatodiolide  (0.02,  0.08  and  0.16  mg/mL)  or  arbutin  
(0.545 mg/mL) for another 24 h. Results are represented as percentages of control, and the 
data are mean ±  SD for three separate experiments. Values are significantly different by 
comparison with control. *** p < 0.001. 
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3. Experimental Section 
3.1. Chemicals and Reagents 
Gallic acid, L-ascorbic acid (AA), Folin-Ciocalteau’s phenol reagent, 1,1-diphenyl-2-picrylhydrazyl 
(DPPH), butylated hydroxyanisole (BHA) and all other chemicals and solvents were obtained from 
Sigma-Aldrich (St. Louis, MO, USA) or Merck. 
3.2. Plant Material, Extraction and Isolation of Pure Compound 
The whole plants of A. indica were collected in September 2010 from the farm of Yusheng Co., Ltd. at 
Taichung in Taiwan, and a botanically identified voucher specimen (AIY-09-28) was deposited in the 
Graduate Institute of Cosmetic Science, Hung Kuang University, Taiwan. Extraction and separation of  
A. indica followed the previous procedures with slight modifications [19,28]. The air-dried whole plants 
(7.8 kg) of A. indica were extracted with methanol (10 L × 4) under reflux. After complete extraction, the 
combined extracts were concentrated under reduced pressure to give a dark brown syrup (296 g, 4.1% 
w/w). The crude extract was then suspended in H2O, defatted with n-hexane, and then partitioned with 
chloroform successively. The concentrated chloroform layer (59 g) was chromatographed on a silica gel 
column by eluting with hexane/ethyl acetate (EtOAc) gradient, with increasing polarity, and yielded six 
fractions (F1–F6). Fraction F4 was subjected to silica gel column chromatography (CC) eluted with 
different solvents of increasing polarity (n-hexane/EtOAc). Fraction F4 (5.5 g) was purified on a silica 
gel column using hexane/EtOAc (8:2) to yield Fraction 4–6 (523 mg). Fraction 4–6 was further separated 
by HPLC (CH3CN–0.1% TFA in H2O, 64:36, UV detection at 265 nm), and simultaneously yielded pure 
ovatodiolide (41 mg) (Figure 1). 
3.3. Cell Culture 
B16F10  cells  (ATCC  CRL-6475,  from  the  BCRC  Cell  Line  Bank,  BCRC60031)  were  cultured  
in  DMEM  with  10%  fetal  bovine  serum  (FBS;  Gibco  BRL,  Gaithersburg,  MD,  USA)  and 
penicillin/streptomycin (100 IU/50 μg/mL) in a humidified atmosphere containing 5% CO2 in air at 37 C. 
All the experiments were performed in triplicate and were repeated 3 times to ensure reproducibility. 
3.4. DPPH Scavenging Activity Assay 
The antioxidant activity of A. indica methanol extract was first determined by measuring the DPPH 
scavenging ability [29] as modified by Sá nchez-Moreno et al. [30]. The methanol extract at various 
concentrations (final concentration 0.05, 0.1, 0.25, 0.5, 1.0 and 1.5 mg/mL) was added to 2.9 mL of 
DPPH (60 µM) solution. When DPPH reacts with an antioxidant that can donate hydrogen, it takes a 
reduced form,  and the  resulting decrease in  absorbance at  517 nm  was recorded using  a UV-Vis 
spectrophotometer (Jasco, V-630, Tokyo, Japan). In this study, BHA (0.01, 0.02 and 0.03 mg/mL) was 
used as antioxidant standard. Int. J. Mol. Sci. 2012, 13  6231 
 
 
3.5. ABTS
+ Scavenging Capacity Assay 
The ABTS decolonization assays were carried out as previously described [31] and involves the 
generation  of  ABTS
+  chromophore  by  oxidation  of  ABTS  with  potassium  persulfate.  The  ABTS 
radical  cation  (ABTS
+)  was  produced  by  reacting  7  mM  stock  solution  of  ABTS  with  2.45  mM 
potassium  persulfate  and  allowing  the  mixture  to  stand  in  the  dark  for  at  least  6  h  before  use. 
Absorbance  at  734  nm  was  measured  10  min  after  mixing  different  concentrations  of  A.  indica 
methanol extract (final concentration 0.05, 0.1, 0.25, 0.5, 1.0 and 1.5 mg/mL) with 1 ml of ABTS
+ 
solution. The ABTS
+ scavenging capacity of A. indica methanol extract was compared with that of 
Trolox
® (0.025, 0.05, 0.075 and 0.1 mg/mL). 
3.6. Determination of Reducing Capacity 
The reducing power of  A. indica methanol extract was determined according to the method of 
Oyaizu [32]. Different concentrations of A. indica methanol extract (0.05, 0.1, 0.2, 0.25, 0.3, 0.4 and 
0.5 mg/mL) or BHA (0.01, 0.02, 0.03 mg/mL) were mixed with phosphate buffer (2.5 mL, 0.2 M,  
pH 6.6) and potassium ferricyanide [K3Fe(CN)6] (2.5 mL, 1% w/v). The mixture was incubated at  
50 C for 20 min. A portion (2.5 mL) of trichloroacetic acid (10% w/v) was added to the mixture, 
which was then centrifuged at 1000 g for 10 min. The upper layer of solution (2.5 mL) was mixed with 
distilled water (2.5 mL) and FeCl3 (0.5 mL, 0.1% w/v), and the absorbance was measured at 700 nm in 
a UV-Vis spectrophotometer. Higher absorbance of the reaction mixture indicated the greater reducing 
power of the test sample. 
3.7. Measurement of Metal-Ion Chelating Capacity 
The chelation of ferrous ions by the A. indica methanol extract or EDTA was determined by the 
previous method described by Dinis et al. [33] with slight modifications. Different concentrations of  
A. indica methanol extract (0.05–2.0 mg/mL) or EDTA (0.04, 0.05, 0.06, 0.07 and 0.08 mg/mL) was 
added to a solution of 1 mM FeCl2 (0.05 mL). Then 0.1 mL of ferrozine (1 mM) was added to the 
reaction mixture and the mixture was quantified to 1 mL with methanol, left standing at 25 C for  
10 min. The absorbance of the reaction mixture was measured at 562 nm. The percentage of chelating 
ability was calculated as follows: chelating ability (%) = (A1 − A2)/A1 ×  100, where A1 is the absorbance 
of control and A2 is the absorbance in the presence of A. indica methanol extract or EDTA. 
3.8. Determination of Total Phenolic Content 
The amount of total phenolics of A. indica methanol extract was determined with the Folin–Ciocalteu 
reagent  [34].  First,  a  standard  curve  was  plotted  using  gallic  acid  as  a  standard  (0.05,  0.1,  0.25,  
0.5 mg/mL). Different concentrations of A. indica methanol extract (0.05, 0.1, 0.25, 0.5, 1.0, 1.5 and 
2.0  mg/mL)  were  prepared  in  80%  of  methanol.  A  100  µL  sample  was  dissolved  in  500  µL  
(1/10 dilution) of the Folin-Ciocalteu reagent and 1000 µL of distilled water. The solutions were mixed 
and incubated at room temperature for 1 min. After 1 min, 1500 µL of 20% sodium carbonate solution 
was added. The final mixture was shaken and then incubated for 2 h in the dark at room temperature. 
The absorbance of samples was measured at 760 nm. Int. J. Mol. Sci. 2012, 13  6232 
 
 
3.9. Assay of Mushroom Tyrosinase Activity 
In order to assay the inhibitory action of A. indica methanol extract (0.25, 0.5 and 1.0 mg/mL) on 
mushroom tyrosinase activity, dose-dependent inhibition experiments were carried out in triplicate as 
described previously with a minor modification [35]. Briefly, 10 mL of aqueous solution of mushroom 
tyrosinase  (200  units)  were  added  to  a  96-well  microplate  in  a  total  volume  of  200  µL  mixture, 
containing 5 mM L-DOPA which is dissolved in 50 mM phosphate buffer (pH 6.8). The assay mixture 
was incubated at 37 C for 30 min. Following incubation, the amount of dopachrome produced in the 
reaction mixture was determined spectrophotometrically at 490 nm (OD490) in a microplate reader. The 
inhibition percentage at three doses for each experiment was calculated by the following equation: 
inhibition percentage of tyrosinase activity (%) = (B − A) ÷  A ×  100, where B is the mean of the 
measured OD490 values of the blank control, and A is the mean of the measured OD490 values for the  
A. indica methanol extract treated group. 
3.10. Measurement of Melanin Content 
The B16F10 intracellular melanin content was measured as described by Tsuboi et al. [36] with 
some modifications. The cells were treated with α-MSH (100 nM) for 24 h, and then the melanin 
content was determined after treatment with either ovatodiolide (final concentration 0.02, 0.08 and 
0.16 mg/mL) or arbutin (0.545 mg/mL) for a further 24 h. After treatment, the cells were detached by 
incubation in trypsin/ethylenediaminetetraacetic acid (EDTA). After precipitation, cell pellets containing 
a known number of cells were solubilized in 1 N NaOH at 60 C for 60 min. The melanin content was 
assayed by spectrophotometric analysis at an absorbance of 405 nm. 
3.11. Assay of B16F10 Intracellular Tyrosinase Activity 
Cellular tyrosinase activity was determined as described previously [37] with slight modifications. 
Briefly, the cells were treated with α-MSH (100 nM) for 24 h, and then intracellular tyrosinase activity 
was measured after treatment with various concentrations of ovatodiolide (final concentration 0.02, 
0.08 and 0.16 mg/mL) or arbutin (0.545 mg/mL) for 24 h. After these treatments, the cells  were 
washed twice with phosphate-buffered saline and homogenized with 50  mM PBS (pH 7.5) buffer 
containing 1.0% Triton X-100 and 0.1 mM PMSF. Intracellular tyrosinase activity was monitored as 
follows:  Cell  extracts  (100  mL)  were  mixed  with  freshly  prepared  L-DOPA  solution  (0.1%  in 
phosphate-buffered saline) and incubated at 37 C. The absorbance at 490 nm was measured with 
microplate  reader  Gen  5™  (BIO-TEK  Instrument,  Bermont,  USA)  to  monitor  the  production  of 
dopachrome, corrected for auto-oxidation of L-DOPA. 
3.12. Statistical Analysis 
Statistical analysis of the experimental data points was performed by the one-way ANOVA test, 
which was used for comparison of measured data using SPSS 12.0 statistical software (4th Edition, 
SPSS INC. Chicago, USA, 2007). The data are presented as mean ±  standard deviation of triplicate 
experiments. Differences were considered as statistically significant at p < 0.05. Int. J. Mol. Sci. 2012, 13  6233 
 
 
4. Conclusions 
In  this  study,  the  methanol  extract  from  A.  indica  showed  potential  antioxidant  activity  and 
ovatodiolide purified from the extract displayed a dermatological effect against melanin production in 
B16F10  melanoma  cells.  This  is  the  first  report  about  the  effect  of  A.  indica  methanol  extract  
and ovatodiolide on melanin production. In the present study, it was found that A. indica methanol  
extract  expresses  antioxidant  activity  and  ovatodiolide  inhibits  melanin  synthesis  significantly  in  a  
dose-dependent pattern. The results revealed that A. indica methanol extract and ovatodiolide could be 
added to skin care cosmetics through antioxidant activity and inhibitory action upon melanin production. 
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